leishmaniasis

This Week in PLOS

In PLOS this week: gut microbial communities of Kenyan children, transcriptional patterns in model of visceral leishmaniasis infection, and more.

This Week in PLOS

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Genetic and immune profiles from Brazilian leishmaniasis cases suggest parasite strain and inflammatory cytokine may contribute to unusual forms of the disease.

In Nucleic Acids Research this week: software package to fix RNA-seq alignment artifacts, differential gene expression profiles of infectious Leishmania, and more.

NEW YORK (GenomeWeb News) – The international non-profit Drugs for Neglected Diseases Initiative (DNDi) and the Institut Pasteur Korea (IP-K) will collaborate to screen for and examine molecules that may be used as new treatments for certain "neglected" diseases, IP-K said today.

The assay was developed by the Army Medical Research and Materiel Command in collaboration with the Walter Reed Army Institute of Research and Cepheid under a collaboration begun in 2005.

The Smart Leish PCR assay is a qualitative real-time PCR test for diagnosing individuals with cutaneous leishmaniasis caused by certain species of sand flies.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.